Yes there is a great deal of interest on dendritic cells. NAVB has some interesting approaches. Very preliminary start up. I am familiar with the modified polio virus used at duke for glioblastoma. not tetanus though.
I have many questions for the new owners of povenge:
As a doc, will they continue the patient assistance programs, pre screening for reimbursement, reimbursement for travel, sales reps, coordinating patients and delivery?
COGS and manufacturing costs were huge. Much higher than any other drug I am aware of. Two big plants, lots of employees. What's their business plan? A new break even? Dndn never came close to theirs in spite of lowering it periodically.